• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.

作者信息

Xiong Q-F, Zhong Y-D, Hu Z-L, Yang Y-F

出版信息

Acta Clin Belg. 2015 Jun;70(3):223-5. doi: 10.1179/2295333714Y.0000000108. Epub 2014 Dec 16.

DOI:10.1179/2295333714Y.0000000108
PMID:25510219
Abstract

We have reported a case of occult hepatitis B virus infection (OBI) associated membranous nephropathy (MN) with complete remission under an ongoing 3.5-year entecavir monotherapy. A 59-year-old man with a 3-year history of liver cirrhosis was introduced to our department because of oliguria, proteinuria and microscopic haematuria. He, with negative serum HBV surface antigen, was not detected HBV DNA in his serum. Renal biopsy was performed and was compatible with a diagnosis of hepatitis B virus-related membranous nephropathy (HBV-MN). The patient was prescribed diuretics and intravenous albumin, and his ascites and oedema remitted gradually. At the same time, entecavir 0.5 mg per day was started. Entecavir treatment was continuing for 3.5 years and finally resulted in complete remission of proteinuria. This suggests that entecavir monotherapy may induce and maintain complete remission of MN associated with OBI.

摘要

相似文献

1
Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
Acta Clin Belg. 2015 Jun;70(3):223-5. doi: 10.1179/2295333714Y.0000000108. Epub 2014 Dec 16.
2
Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.恩替卡韦单药治疗后乙型肝炎病毒相关膜性肾病完全缓解。
Clin Res Hepatol Gastroenterol. 2012 Oct;36(5):e89-92. doi: 10.1016/j.clinre.2012.03.033. Epub 2012 May 7.
3
Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.恩替卡韦使一名乙型肝炎病毒相关性膜性肾病患儿的乙型肝炎e抗原发生血清学转换。
J Nippon Med Sch. 2013;80(5):387-95. doi: 10.1272/jnms.80.387.
4
Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.恩替卡韦治疗乙型肝炎病毒相关膜性肾病的疗效观察
J Trop Pediatr. 2018 Jun 1;64(3):249-252. doi: 10.1093/tropej/fmx058.
5
Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.拉米夫定单药治疗后乙肝病毒相关性膜性肾小球病所致肾病综合征完全缓解
J Formos Med Assoc. 2007 Oct;106(10):869-73. doi: 10.1016/S0929-6646(08)60054-6.
6
Hepatitis B virus-related membranous nephropathy treated with entecavir.
Nephrology (Carlton). 2010 Mar;15(2):266. doi: 10.1111/j.1440-1797.2009.01165.x.
7
Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.恩替卡韦治疗乙型肝炎病毒相关性膜性肾病的疗效。
Rev Esp Enferm Dig. 2020 Nov;112(11):843-849. doi: 10.17235/reed.2020.6762/2019.
8
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.恩替卡韦单药治疗可有效抑制肝移植后乙型肝炎病毒。
Gastroenterology. 2011 Oct;141(4):1212-9. doi: 10.1053/j.gastro.2011.06.083. Epub 2011 Jul 14.
9
Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.急性乙型肝炎病毒感染后短期内发生的与慢性乙型肝炎相关的膜性肾病。
Intern Med. 2010;49(5):383-8. doi: 10.2169/internalmedicine.49.2812. Epub 2010 Mar 1.
10
Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.恩替卡韦与拉米夫定用于血液病患者乙型肝炎的预防。
Liver Int. 2013 Sep;33(8):1203-10. doi: 10.1111/liv.12154. Epub 2013 Mar 24.

引用本文的文献

1
Frequency of OBI among Patients with Autoimmune Hepatitis.自身免疫性肝炎患者中 OBI 的频率。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2555-2559. doi: 10.31557/APJCP.2020.21.9.2555.